FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012647950> ?p ?o ?g. }

• W2012647950 endingPage "46" @default.
• W2012647950 startingPage "39" @default.
• W2012647950 abstract "This study aimed to verify the effect of the treatment with A. satureioides essential oil (free and nanoencapsulated forms) and diminazene aceturate on hematological and biochemical variables in rats infected by Trypanosoma evansi. The 56 rats were divided into seven groups with eight rats each. Groups A, C and D were composed by uninfected animals, and groups B, E, F and G were formed by infected rats with T. evansi. Rats from groups A and B were used as negative and positive control, respectively. Rats from the groups C and E were treated with A. satureioides essential oil, and groups D and F were treated with A. satureioides nanoencapsulated essential oil. Groups C, D, E and F received one dose of oil (1.5 mL kg−1) during five consecutive days orally. Group G was treated with diminazene aceturate (D.A.) in therapeutic dose (3.5 mg kg−1) in an only dose. The blood samples were collected on day 5 PI for analyses of hematological (erythrocytes and leukocytes count, hemoglobin concentration, hematocrit, mean corpuscular and mean corpuscular hemoglobin concentration) and biochemical (glucose, triglycerides, cholesterol, alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin, urea and creatinine) variables. A. satureioides administered was able to maintain low parasitemia, mainly the nanoencapsulated form, on 5 days post infection. On the infected animals with T. evansi treated with A. satureioides essential oil (free and nanocapsules) the number of total leucocytes, lymphocytes and monocytes present was similar to uninfected rats, and different from infected and not-treated animals (leukocytosis). Treatment with A. satureioides in free form elevated levels of ALT and AST, demonstrating liver damage; however, treatment with nanoencapsulated form did not cause elevation of these enzymes. Finally, treatments inhibited the increase in creatinine levels caused by infection for T. evansi. In summary, the nanoencapsulated form showed better activity on the trypanosome; it did not cause liver toxicity and prevented renal damage." @default.
• W2012647950 created "2016-06-24" @default.
• W2012647950 creator A5011685038 @default.
• W2012647950 creator A5014352930 @default.
• W2012647950 creator A5019527270 @default.
• W2012647950 creator A5022367997 @default.
• W2012647950 creator A5032181986 @default.
• W2012647950 creator A5034310678 @default.
• W2012647950 creator A5040932536 @default.
• W2012647950 creator A5042577084 @default.
• W2012647950 creator A5045131615 @default.
• W2012647950 creator A5046559485 @default.
• W2012647950 creator A5052950278 @default.
• W2012647950 creator A5055729946 @default.
• W2012647950 creator A5063691024 @default.
• W2012647950 creator A5085507704 @default.
• W2012647950 creator A5091073374 @default.
• W2012647950 date "2015-02-01" @default.
• W2012647950 modified "2023-10-14" @default.
• W2012647950 title "Effect of the treatment with Achyrocline satureioides (free and nanocapsules essential oil) and diminazene aceturate on hematological and biochemical parameters in rats infected by Trypanosoma evansi" @default.
• W2012647950 cites W1964145203 @default.
• W2012647950 cites W1964592536 @default.
• W2012647950 cites W1967365348 @default.
• W2012647950 cites W1971277317 @default.
• W2012647950 cites W1972819738 @default.
• W2012647950 cites W1976589017 @default.
• W2012647950 cites W1978994127 @default.
• W2012647950 cites W1985450391 @default.
• W2012647950 cites W1993643603 @default.
• W2012647950 cites W1999550448 @default.
• W2012647950 cites W2000978189 @default.
• W2012647950 cites W2002001112 @default.
• W2012647950 cites W2003223870 @default.
• W2012647950 cites W2008126851 @default.
• W2012647950 cites W2008709126 @default.
• W2012647950 cites W2016033900 @default.
• W2012647950 cites W2016675477 @default.
• W2012647950 cites W2016955921 @default.
• W2012647950 cites W2017252148 @default.
• W2012647950 cites W2017492570 @default.
• W2012647950 cites W2025131851 @default.
• W2012647950 cites W2025206271 @default.
• W2012647950 cites W2027237928 @default.
• W2012647950 cites W2028378564 @default.
• W2012647950 cites W2028640483 @default.
• W2012647950 cites W2030727129 @default.
• W2012647950 cites W2031228686 @default.
• W2012647950 cites W2032703417 @default.
• W2012647950 cites W2033774200 @default.
• W2012647950 cites W2038237422 @default.
• W2012647950 cites W2041780889 @default.
• W2012647950 cites W2046606679 @default.
• W2012647950 cites W2049810346 @default.
• W2012647950 cites W2055285179 @default.
• W2012647950 cites W2057464734 @default.
• W2012647950 cites W2058256110 @default.
• W2012647950 cites W2059633611 @default.
• W2012647950 cites W2061468483 @default.
• W2012647950 cites W2062544356 @default.
• W2012647950 cites W2068642841 @default.
• W2012647950 cites W2068905218 @default.
• W2012647950 cites W2069241757 @default.
• W2012647950 cites W2070659918 @default.
• W2012647950 cites W2077193151 @default.
• W2012647950 cites W2087140780 @default.
• W2012647950 cites W2089685702 @default.
• W2012647950 cites W2102223574 @default.
• W2012647950 cites W2107802094 @default.
• W2012647950 cites W2144907950 @default.
• W2012647950 cites W2160587554 @default.
• W2012647950 cites W2492094646 @default.
• W2012647950 cites W4293761842 @default.
• W2012647950 doi "https://doi.org/10.1016/j.exppara.2014.12.005" @default.
• W2012647950 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25499512" @default.
• W2012647950 hasPublicationYear "2015" @default.
• W2012647950 type Work @default.
• W2012647950 sameAs 2012647950 @default.
• W2012647950 citedByCount "24" @default.
• W2012647950 countsByYear W20126479502016 @default.
• W2012647950 countsByYear W20126479502017 @default.
• W2012647950 countsByYear W20126479502019 @default.
• W2012647950 countsByYear W20126479502020 @default.
• W2012647950 countsByYear W20126479502021 @default.
• W2012647950 countsByYear W20126479502022 @default.
• W2012647950 countsByYear W20126479502023 @default.
• W2012647950 crossrefType "journal-article" @default.
• W2012647950 hasAuthorship W2012647950A5011685038 @default.
• W2012647950 hasAuthorship W2012647950A5014352930 @default.
• W2012647950 hasAuthorship W2012647950A5019527270 @default.
• W2012647950 hasAuthorship W2012647950A5022367997 @default.
• W2012647950 hasAuthorship W2012647950A5032181986 @default.
• W2012647950 hasAuthorship W2012647950A5034310678 @default.
• W2012647950 hasAuthorship W2012647950A5040932536 @default.
• W2012647950 hasAuthorship W2012647950A5042577084 @default.
• W2012647950 hasAuthorship W2012647950A5045131615 @default.
• W2012647950 hasAuthorship W2012647950A5046559485 @default.
• W2012647950 hasAuthorship W2012647950A5052950278 @default.
• W2012647950 hasAuthorship W2012647950A5055729946 @default.

• next